Most widely recognized RCC-CSCs biomarker - endoglin that is CD105 - surface expression is to be distinctive for these cells, and within the tumor only a small subpopulation is expected to express this protein, as CSCs usually represent minor fraction of the total tumor mass. This evidence concerns the gene ENG and renal cell carcinoma.